The Vaccine Contract Manufacturing Market Will Reach $1047.3m In 2019 Predicts New Visiongain Report

13 September 2018
Pharma

A new report by visiongain predicts that the global vaccine contract manufacturing market will reach $1047.3m in 2019. This forecast and others appear in Vaccine Contract Manufacturing Market Report 2016-2026: Leading Countries, Technologies and Companies, published in December 2015. Visiongain is a business information provider based in London, UK.

Vaccine Contract Manufacturing Market Report 2016-2026: Leading Countries, Technologies and Companies examines the current and future trends in the vaccine contract manufacturing market. Vaccines are a healthcare success, with widespread immunisation eradicating some of the world’s most deadly diseases. The development of new vaccines has historically been limited to a number of large companies due to the high costs involved. However, a growing number of virtual companies and the international demand for new therapeutic vaccines especially, growth in the vaccine contract manufacturing market is accelerating. Another key aspect of the market is the rise of emerging markets as not only a destination for vaccines, but as high quality manufacturing centres for them. While visiongain does not believe this will completely reshape the market, its effects cannot be discounted.

In this report, visiongain examines in detail a number of key national markets (US, Germany, UK, France, Spain, Italy, Japan, China, Russia, Brazil and India), as well as looking at the overall vaccine contract manufacturing market and the key players within it. To give scale to the contract manufacturing business, a global vaccines market forecast is also included. Using visiongain’s experience and market knowledge, as well as a wide variety of sources, forecasts have been built for both national and overall markets, accompanied by text giving a thorough explanation of events thought to shape the market currently and in the future.

Visiongain’s report provides revenue forecasts to 2026 for the vaccine contract manufacturing market and its leading national markets. The report discusses selected leading companies which hold significant shares of the market. These companies include Baxter BioPharma Solutions, Boehringer Ingelheim, Catalent, Charles River Laboratories, IDT Biologika, Lonza, Meridian Life Science, Sigma Aldrich Fine Chemicals (Merck) and Synco Bio Partners.

Vaccine Contract Manufacturing Market Report 2016-2026: Leading Countries, Technologies and Companies adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100
About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever